Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8.
Morozumi K, Mitsuzuka K, Narita S, Takahashi M, Kawamura S, Tochigi T, Arai Y, Hoshi S, Shimoda J, Ishidoya S, Okamoto T, Hatakeyama S, Sakurai T, Tsuchiya N, Ohyama C, Habuchi T, Ito A.
Morozumi K, et al.
Int J Urol. 2022 Apr;29(4):324-331. doi: 10.1111/iju.14781. Epub 2022 Jan 18.
Int J Urol. 2022.
PMID: 35042278
Clinical Trial.